MYEFO allocates $103 million to research funding
18 December, 2013The Australian Government's Mid-year Economic and Fiscal Outlook (MYEFO), released yesterday, redirected $103 million to funding research which, according to Minister for Education Christopher Pyne, will help researchers deliver outcomes that will have significant benefit to the nation through the Australian Research Council (ARC).
Admedus acquires manufacturing facility from Genzyme Australasia
13 December, 2013Healthcare group Admedus (formerly Allied Healthcare) has signed a share purchase agreement to acquire an established manufacturing site from Genzyme Australasia, a Sanofi company. Admedus purchased the site to facilitate scaled-up production of its regenerative tissue product CardioCel.
So you've got a genius idea - now what?
13 December, 2013Intellectual assets can be commercialised but the road from idea to marketplace success can be fraught. Frequently those with the original genius idea are not by nature entrepreneurial or commercially savvy - this is especially true with those from a research or academic background and turning an intellectual asset into something tradable is not a simple, straightforward process.
Lorne conference season 2014
12 December, 2013The seaside town of Lorne, less than two hours' drive from Melbourne, will soon host its traditional series of life sciences conferences. The Mantra Lorne offers beachfront accommodation surrounded by 12 acres of landscaped gardens, making it an ideal setting for the two-week conference series.
Academy claims more science investment needed
03 December, 2013The Australian Academy of Science has presented a submission to the National Commission of Audit, arguing that Australia’s investment in science is moving backwards.
Ascend and 3M to collaborate on cancer vaccine
02 December, 2013US multinational 3M Drug Delivery Systems has partnered with Melbourne-based immunotherapy biotech Ascend Biopharmaceuticals to work on cancer vaccines targeting solid tumour types which incorporate aspects of both companies' technology.
Australian Innovation Challenge 2013 winners announced
02 December, 2013Eight of the country's best innovators were recognised last week in the third annual The Australian Innovation Challenge. The challenge is run by The Australian in partnership with Shell Australia with support from the Department of Industry and Innovation Australia.
Science talk at Sydney's Royal Botanic Garden
29 November, 2013The Royal Botanic Gardens and Domain Trust is hosting a talk on plant conservation at the Royal Botanic Garden Sydney on 9 December.
Fred Hollows Foundation and International Diabetes Federation to tackle diabetic blindness
29 November, 2013The Fred Hollows Foundation has signed up to a 10-year partnership with the International Diabetes Federation to tackle a complication of the disease that can lead to blindness. The agreement was announced just days before the start of the World Congress on Diabetes in Melbourne, to be attended by over 10,000 delegates and 400 exhibitors from 2-6 December.
Morrison & Foerster releases BioMeter index for Q3
27 November, 2013Law firm Morrison & Foerster (MoFo) has released its latest BioMeter index, a quarterly deal report which measures the health of the biotechnology industry by tracking up-front licensing payments for pharma and biotech assets.
Biological scientist named WA's Tall Poppy for 2013
27 November, 2013Professor Ryan Lister, a genome biologist and Future Fellow in the ARC Centre for Excellence in Plant Energy Biology, has won the 2013 Tall Poppy Awards for Western Australia.
Research scholarships to help the sugarcane industry
26 November, 2013Sugar Research Australia (SRA) is calling for applications for research funding and postgraduate scholarships that will help build the profitability, productivity and sustainability of the Australian sugarcane industry.
Nancy Millis Medal to honour women in science
22 November, 2013The Australian Academy of Science has created a new award - the Nancy Millis Medal - which recognises outstanding research and leadership by early- to mid-career Australian women who have established independent research in the natural sciences.
Merck Biopharm osteoarthritis co-research agreement
22 November, 2013Biopharm and Merck Serono have entered a joint discovery project focusing on a potential pro-anabolic osteoarthritis modifying drug based on a growth factor derived from the Biopharm growth factor platform technology.
Questacon celebrates 25th anniversary
22 November, 2013Saturday 23 November marks the 25th anniversary of Questacon - The National Science and Technology Centre. The multiaward-winning tourist attraction features eight galleries with over 200 interactive exhibits.